ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings.

Autor: Kassem AM; Center for Human Genetics, University Hospitals Cleveland Medical Center.; Clinical Pathology Department, Faculty of Medicine, Assiut University, Egypt., Keinath MC; Center for Human Genetics, University Hospitals Cleveland Medical Center.; Department of Pathology, University Hospitals Cleveland Medical Center., Adler JA; Case Western Reserve University School of Medicine.; Department of Hematology, University Hospitals Cleveland Medical Center., Gadde R; Department of Pathology, University Hospitals Cleveland Medical Center.; Case Western Reserve University School of Medicine., Tomlinson BK; Case Western Reserve University School of Medicine.; Department of Hematology, University Hospitals Cleveland Medical Center., Shetty S; Center for Human Genetics, University Hospitals Cleveland Medical Center.; Department of Pathology, University Hospitals Cleveland Medical Center.; Case Western Reserve University School of Medicine.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2023 Sep; Vol. 202 (6), pp. 1077-1078. Date of Electronic Publication: 2023 Jul 26.
DOI: 10.1111/bjh.18950
Databáze: MEDLINE
Externí odkaz: